Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses
Pepa Bruce(Medical Research Institute of New Zealand), Alistair Nichol(University College Dublin), Lee Hatter(Victoria University of Wellington), Scott Berry(Queen's University), Susan C. Morpeth, David Cosgrave(Ollscoil na Gaillimhe – University of Galway), Paul J. Young(Wellington Hospital), Richard Beasley(Medical Research Institute of New Zealand), Kate Ainscough, Irene Braithwaite(Medical Research Institute of New Zealand), Thomas Hills(Auckland City Hospital), Alex Semprini(Medical Research Institute of New Zealand), Lindsay R. Berry(Berry & Associates (United States)), Peter Doran(University College Dublin), Kathy Brickell(University College Dublin), Mark Fitzgerald(Children's Hospital of Philadelphia)
Cited by 1
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980